期刊
INFECTION AND IMMUNITY
卷 73, 期 9, 页码 6191-6193出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/IAI.73.9.6191-6193.2005
关键词
-
资金
- NIAID NIH HHS [KO8 AI060641, K08 AI060641, P01 AI037194, R01 AI19990, P01 AI37194, R03 AI054531, R01 AI019990] Funding Source: Medline
- NIDCR NIH HHS [R01 DE013974] Funding Source: Medline
- PHS HHS [R01 A1054928] Funding Source: Medline
We have previously shown that intraperitoneal vaccination with the recombinant N terminus of Als1p (rAls1p-N) modestly improves survival during murine disseminated candidiasis. We now report marked efficacy with subcutaneous rAls1p-N vaccination. Efficacy is retained in neutropenic and corticosteroid-treated mice. The rAls1p-N vaccine is a promising candidate for the prevention of invasive candidiasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据